Verition Fund Management »

Regeneron Pharmaceuticals shares owned by Verition Fund Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $311k 1.8k 171.07
2012-06-30 $1.3M 11k 114.20

More positions owned by Verition Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
salesforce Call Option (CRM)
Apple Call Option (AAPL)
Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Ishares Msci Brazil Etf Put Option (EWZ)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Goldman Sachs (GS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Sea Note 2.375%12/0 (Principal)

View all positions for Verition Fund Management

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals